Literature DB >> 18155662

Increased activity of phosphatase PP2A in the presence of the PlA2 polymorphism of alphaIIbbeta3.

Huili Wang1, Bin Yan, Lisa L Satterwhite, Qi Ma, Pascal J Goldschmidt-Clermont.   

Abstract

Polymorphisms in alphaIIbbeta3 are important genetic factors that alter platelet biology and have been associated with susceptibility to thromboembolic disorders. To define the molecular mechanisms that lead to variance in thrombotic diathesis dictated by the beta3 polymorphism, we examined regulation of intracellular signaling by alphaIIbbeta3, and studied the effects of a common beta subunit PlA2 polymorphism. We found that PP2A regulates alphaIIbbeta3 control of the ERK signaling in a polymorphism specific fashion. In CHO cells, exogenous expression of alphaIIbbeta3 reduced ATP-stimulated ERK phosphorylation and more so for PlA2 than PlA1. Interestingly, reduced level of ERK phosphorylation correlated with an increase in PP2A activity, with higher activity associated with PlA2 than PlA1. We tested the effect of PP2A on alphaIIbbeta3-dependent adhesion, and found that PP2A overexpression increased cell adhesion, while phosphatase inhibitors decreased cell adhesion. We propose that PlA2 alters cell signaling at least in part by increasing beta3-associated PP2A activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155662      PMCID: PMC2275810          DOI: 10.1016/j.bbrc.2007.12.094

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

1.  Negative regulation of mitogen-activated protein kinase activation by integrin alphaIIbbeta3 in platelets.

Authors:  F Nadal; S Lévy-Toledano; F Grelac; J P Caen; J P Rosa; M Bryckaert
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.

Authors:  S E Bojesen; S K Kjaer; E V S Høgdall; B L Thomsen; C K Høgdall; J Blaakaer; A Tybjaerg-Hansen; B G Nordestgaard
Journal:  Endocr Relat Cancer       Date:  2005-12       Impact factor: 5.678

3.  PlA2 polymorphism and efficacy of aspirin.

Authors:  G E Cooke; P F Bray; J D Hamlington; D M Pham; P J Goldschmidt-Clermont
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

4.  PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.

Authors:  P M Ridker; C H Hennekens; C Schmitz; M J Stampfer; K Lindpaintner
Journal:  Lancet       Date:  1997-02-08       Impact factor: 79.321

5.  Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study.

Authors:  D Feng; K Lindpaintner; M G Larson; V S Rao; C J O'Donnell; I Lipinska; C Schmitz; P A Sutherland; H Silbershatz; R B D'Agostino; J E Muller; R H Myers; D Levy; G H Tofler
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

6.  Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin.

Authors:  B Favre; P Turowski; B A Hemmings
Journal:  J Biol Chem       Date:  1997-05-23       Impact factor: 5.157

7.  Integrin beta3 Leu33Pro polymorphism and breast cancer risk: a population-based case-control study in Germany.

Authors:  Shan Wang-Gohrke; Jenny Chang-Claude
Journal:  Breast Cancer Res Treat       Date:  2004-12       Impact factor: 4.872

8.  Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.

Authors:  S Resjö; A Oknianska; S Zolnierowicz; V Manganiello; E Degerman
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

9.  A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

Authors:  E J Weiss; P F Bray; M Tayback; S P Schulman; T S Kickler; L C Becker; J L Weiss; G Gerstenblith; P J Goldschmidt-Clermont
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

10.  Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells.

Authors:  N Chajry; P M Martin; C Cochet; Y Berthois
Journal:  Eur J Biochem       Date:  1996-01-15
View more
  1 in total

Review 1.  Negative regulators of platelet activation and adhesion.

Authors:  L Stefanini; W Bergmeier
Journal:  J Thromb Haemost       Date:  2017-12-26       Impact factor: 5.824

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.